NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Shenzhen Genocury Biotechnology Co., Ltd.

Shenzhen Genocury Biotechnology Co., Ltd.

Private
ShenzhenHealthcare & Life Scienceshttp://genocury.com/

Last Round

Series D

Nov 1, 2025

Est. Valuation

$610M

Total Funding Raised

$276.59M

Company Overview

Shenzhen Genocury Biotechnology Co., Ltd. is a biotechnology company that focuses on the research and development of gene and cell therapies for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

in vivo cell therapygene therapyCAR-T therapyCAR-NK cell therapyin vivo deliverynext-gen CAR-Tcell engineeringoncologyautoimmune disordersdrug developmentclinical trialsbiotechoff-the-shelf therapyviral delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shenzhen Genocury Biotechnology Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Shenzhen Genocury Biotechnology Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Shenzhen Genocury Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DNov 1, 2025
Series AJun 18, 2024
Angel ExtensionMay 15, 2024
Early FundingApr 21, 2023
AngelJan 31, 2023
Series C
Jul 22, 2021

Shenzhen Genocury Biotechnology Co., Ltd. Investors

Notable investors and investment history

Shenzhen Genocury Biotechnology Co., Ltd. investors
InvestorRounds
Weiting CapitalSeries C
Beijing Chang DevelopmentSeries D
Chuanghehui CapitalSeries C
Highlight CapitalSeries B Extension
Desun CapitalSeries B
Baidu VenturesSeries C
Tianjin Venture Capital Management Co., Ltd.Angel Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2023

    Honghui Capital participated in the early funding round.

  • Jul 22, 2021

    $116M round led by CCB International.

Shenzhen Genocury Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shenzhen Genocury Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shenzhen Genocury Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Year Founded2021
Last FundingNov 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.